nbsp   What is Canadas role in nuclear medicine and isotope production?
[A. CANDU Technology] [B. The Industry] [C. Cost/Benefit] [D. Safety/Liability] [E. Waste] [F. Security/Non-Proliferation] [G. Uranium] [H. Research Reactors] [I. Other R&D] [J. Further Info] Canada has been a world-leader in the medical applications of nuclear energy since the start of its nuclear program. Canada pioneered the Cobalt-60 cancer therapy technology that became standard medical practice throughout the world (the first Cobalt-60 cancer therapy was administered at the Royal Victoria Hospital in London, Ontario on October 27, 1951), and has also been involved in the development of accelerator-based cancer therapy technology. Currently, about 85% of the world’s medical and industrial Cobalt-60 is produced in Canada. The medical-use Cobalt-60 is produced in the NRU research reactor at AECL’s Chalk River Laboratories, while industrial-use Cobalt-60 is produced in selected CANDU power reactors (in these units some adjuster rods are made of Cobalt-59 for this purpose). Furthermor
